Sep 10, 2014
LITTLE ROCK, Ark. (September 10, 2014) – Cantrell Drug Company today announced it has entered into an exclusive agreement to become the first human drug compounding outsourcing facility to utilize Aseptic Technologies’ closed vial system for aseptic filling of injectable drugs. Outsourcing facilities were created under the federal Drug Quality and Security Act (DQSA) enacted in November 2013.
Under the agreement, Cantrell Drug Company will prepare sterile compounded medications with Aseptic Technologies’ Crystal® Closed Vial Technology, which was designed to increase patient safety by vastly reducing the risk of contamination during the complex filling process used by sterile compounding pharmacies and outsourcing facilities. The new technology simplifies and reduces the risk associated with the glass vial filling process used by pharmaceutical manufacturers. Additionally, it provides easier handling for pharmacists and hospital staff who dispense medication.
“This technology represents a revolutionary advance for Cantrell Drug Company, as well as for the sterile product industry in general,” said Dell McCarley, Chief Executive Officer of Cantrell Drug Company. “We decided to invest in the Crystal Closed Vial Technology because of the high level of quality assurance it will offer to our customers in the hospital market and, by extension, the patients they serve.”
Under the closed vial process, each vial will be assembled in a clean room and sterilized by gamma irradiation before being delivered, ready to fill, to Cantrell Drug Company. A Crystal robotic system in a SKAN isolator fills each vial by piercing the elastic stopper with a special needle, delivering the liquid, and quickly re-sealing the opening with the zap of a laser. Vials are covered with a specially designed cap which health care providers eventually open to withdraw the sterile medication and administer to patients.
Cantrell Drug Company regularly supplies hospitals with sterile compounded medications, some of which are commercially unavailable and others that are simple admixtures. The company is the first U.S. compounding pharmacy to partner with Aseptic Technologies, a Belgium-based business which was spun out of GSK Biologicals, a subsidiary of global pharmaceutical company GlaxoSmithKline, in 2002.
“The collaboration with Cantrell Drug Company is a real opportunity to offer the benefits of the best aseptic technology to a broad base of patients in the United States,” said Aseptic Technologies CEO Patrick Balériaux. “At Aseptic Technologies, we are very proud and excited to actively participate with Cantrell Drug Company in continuing the improvement of drug safety in hospitals thanks to our Crystal Closed Vial Technology and our versatile robotic equipment to be installed in SKAN isolators.”
The Aseptic Technologies partnership continues Cantrell Drug Company’s tradition of innovation and investment to achieve the highest quality standards. Earlier this year, the company was among the first large-scale sterile compounding pharmacies in the nation to register as an outsourcing facility with the U.S. Food and Drug Administration (FDA) and follow more rigorous standards established by the DQSA. Prior to this registration, Cantrell Drug Company had voluntarily listed drug products with the FDA.
“At Cantrell, patient safety is our top priority and that’s why we are always evaluating our operations and seeking opportunities to enhance quality assurance,” said Mike Pierce, President of Cantrell Drug Company. “We believe our investment in the closed vial technology takes us to another level of quality and safety, one that is unsurpassed in the sterile compounding industry.”
About Cantrell Drug Company
Founded in 1952, Cantrell Drug Company is a leading FDA-registered supplier of outsourced pharmacy preparations, specializing in providing custom IV admixtures, epidural preparations, PCA syringes, OR syringes, and drug shortage formulations with the highest quality standards. Cantrell Drug Company provides sterile and non-sterile compounded preparations that meet the needs of patients, physicians, clinics and health care institutions. Based in Little Rock, Ark., Cantrell Drug Company retains state licenses nationwide, a DEA manufacturing license, and an FDA registration.
|Jan 18, 2018||Winland Hires Manager of the Reseller Partner Channel|
|Jan 10, 2018||American Associated Pharmacies Selects FDS ECONCILE Reconciliation and Claims Ma...|
|Dec 27, 2017||RxOneShop Is Proud to Sponsor and Invite You to Pharmacy Owners Boot Camp|
|Dec 20, 2017||UPMC Chooses Revolutionary Technology from Omnicell to Elevate and Automate Phar...|
|Dec 18, 2017||Medicine-On-Time Announces Long-Term Distribution Partnership and Purchase of Ma...|
|Dec 14, 2017||iMedicare and Creative Pharmacist Announce Strategic Partnership|
|Dec 13, 2017||American BioTech Supply Introduces Webpages Dedicated to Natural Refrigerant Tec...|
|Dec 08, 2017||Azzur Labs Expands Accreditation|
|Dec 08, 2017||Azzur Labs Named Fourth Best Place To Work in PA|
|Dec 06, 2017||Hacettepe University Oncology Hospital Introduces Omnicell i.v.STATION ONCO Robo...|
|Dec 01, 2017||Swisslog Healthcare Launches Next-Generation Pharmacy Analytics Platform To Tran...|
|Nov 28, 2017||Omnicell Introduces Revolutionary New Solution to Automate Critical Workflows in...|
|Nov 22, 2017||R.J. Hedges & Associates Named 2017 Torch Award for Ethics by BBB|
|Nov 17, 2017||BestRx First Pharmacy Dispensing Software Company to Achieve Level 2 – Pharmac...|
|Nov 16, 2017||Introducing Accreditation Commission for Health Care as a Thought Leader in Phar...|
|Nov 15, 2017||Medi-Dose®, Inc. / EPS®, Inc. Now Markets Steri-Tamp® Tamper-Clear Syringe...|
|Nov 14, 2017||Omnicell Supports Global Charity Mercy Ships by Donating Next Generation XT Seri...|
|Nov 14, 2017||Medi-Dose, Inc. Announces NEW MPB™ Multi-Purpose Blister|
|Nov 13, 2017||OmniSYS Announces Strategic Partnership with PerceptiMed|
|Nov 02, 2017||Contec, Inc. Recognized as One of America's Healthiest Organizations by American...|
|Nov 02, 2017||Introducing Apexus as a Thought Leader in 340B Drug Pricing and Education|
|Oct 31, 2017||Medicine-On-Time and Clinical Support Services Announce the Formation of Star MT...|
|Oct 26, 2017||Hackensack Meridian Health Expands Contract with Omnicell for Medication Managem...|
|Oct 26, 2017||iMedicare and American Associated Pharmacies Partner to Help Independent Pharmac...|
|Oct 25, 2017||Medi-Dose, Inc. / EPS, Inc. Announces Expanded Line of Resealable and Ultraviole...|
|Oct 25, 2017||Riverside Medical Center Selects Omnicell's Medication Management Solutions to E...|
|Oct 25, 2017||Kinney Drugs 1st Patient-Centered Pharmacy Home™ Accreditation Recipient|
|Oct 24, 2017||Dana Rafferty Named Akro-Mils Executive Director of Sales and Marketing|
|Oct 23, 2017||Medi-Dose/EPS Announces TampAlerT® Tamper-Evident Cap for ENFit™ Syringes|
|Oct 20, 2017||Phononic Honored by Goldman Sachs for Entrepreneurship|
Connect with thousands of pharmacy professionals throughout every practice setting.